StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -A$13.28M. The highest annual figure on record is -A$6.71M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Jun 30, 2025-A$13.28M–
FY2024Jun 30, 2024-A$9.58M–
FY2023Jun 30, 2023-A$15.16M–
FY2022Jun 30, 2022-A$22.76M–
FY2021Jun 30, 2021-A$9.11M–
FY2020Jun 30, 2020-A$8.81M–
FY2019Jun 30, 2019-A$6.71M–
FY2018Jun 30, 2018-A$8.66M–
FY2017Jun 30, 2017-A$11.44M–
FY2016Jun 30, 2016-A$11.98M–

More Kazia Therapeutics figures

See a number that looks wrong?